BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35588793)

  • 21. Women's informed choice and satisfaction with immediate postpartum long-acting reversible contraception in Georgia.
    DeSisto CL; Handler A; Haider S; Caskey R; Peacock N; Kottke M; Rankin K
    Contracept Reprod Med; 2018; 3():19. PubMed ID: 30524752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients' Experiences with an Immediate Postpartum Long-Acting Reversible Contraception Program.
    Wallace Huff C; Potter JE; Hopkins K
    Womens Health Issues; 2021; 31(2):164-170. PubMed ID: 33323329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of Publicly Available State Policies for Long-Acting Reversible Contraception Device Reimbursement.
    Romero L; Sappenfield OR; Uesugi K; Howland JF; Kroelinger CD; Okoroh EM; Erondu C; Cox S
    J Womens Health (Larchmt); 2022 Jul; 31(7):1048-1056. PubMed ID: 35041489
    [No Abstract]   [Full Text] [Related]  

  • 24. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.
    Kotha A; Chen BA; Lewis L; Dunn S; Himes KP; Krans EE
    Contraception; 2019 Jan; 99(1):36-41. PubMed ID: 30114393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State-Identified Implementation Strategies to Increase Uptake of Immediate Postpartum Long-Acting Reversible Contraception Policies.
    Kroelinger CD; Morgan IA; DeSisto CL; Estrich C; Waddell LF; Mackie C; Pliska E; Goodman DA; Cox S; Velonis A; Rankin KM
    J Womens Health (Larchmt); 2019 Mar; 28(3):346-356. PubMed ID: 30388052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of COVID-19 and Policy Changes on Immediate Postpartum Contraception and Permanent Contraception at an Urban Hospital: A Retrospective Cohort Study.
    Jensen R; Habib A; Lenus S; Lee J
    J Womens Health (Larchmt); 2023 Dec; 32(12):1340-1345. PubMed ID: 37902780
    [No Abstract]   [Full Text] [Related]  

  • 27. Association of the Delaware Contraceptive Access Now Initiative with Postpartum LARC Use.
    Caudillo ML; Hurtado-Acuna C; Rendall MS; Boudreaux M
    Matern Child Health J; 2022 Aug; 26(8):1657-1666. PubMed ID: 35488950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between immediate postpartum long-acting reversible contraception and short interpregnancy intervals.
    Wu M; Eisenberg R; Negassa A; Levi E
    Contraception; 2020 Dec; 102(6):409-413. PubMed ID: 32918870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing long-acting reversible contraception insertion rates in women with Medicaid vs. private insurance in a clinic with a two-visit protocol.
    Higgins TM; Dougherty AK; Badger GJ; Heil SH
    Contraception; 2018 Jan; 97(1):76-78. PubMed ID: 28887052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease.
    Sinkey RG; Blanchard CT; Maier J; Novara A; Mazzoni SE; Goepfert AR; Boozer M; Rajapreyar I; Cribbs M; Szychowski JM; Tita ATN
    Contraception; 2022 Jan; 105():55-60. PubMed ID: 34529951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicaid Payment For Postpartum Long-Acting Reversible Contraception Prompts More Equitable Use.
    Quinlan TAG; Lindrooth RC; Guiahi M; McManus BM; Mays GP
    Health Aff (Millwood); 2023 May; 42(5):665-673. PubMed ID: 37126756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in Postpartum Contraceptive Use in 20 U.S. States and Jurisdictions: The Pregnancy Risk Assessment Monitoring System, 2015-2018.
    Bruce K; Stefanescu A; Romero L; Okoroh E; Cox S; Kieltyka L; Kroelinger C
    Womens Health Issues; 2023; 33(2):133-141. PubMed ID: 36464580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Special report: implementing immediate postpartum LARC in Florida.
    Brown JA; Greenfield LT; Rapkin RB
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S906-S909. PubMed ID: 31866518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postpartum long-acting reversible contraception among privately insured: U.S. National analysis 2007-2016, by term and preterm birth.
    Shaw JG; Goldthwaite LM; Marić I; Shaw KA; Stevenson DK; Shaw GM
    Contraception; 2023 Sep; 125():110065. PubMed ID: 37210023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examining the association between short interpregnancy interval births and the type and timing of postpartum long acting reversible contraception.
    Rodriguez MI; Skye M; Ramanadhan S; Schrote K; Darney BG
    Contraception; 2022 Aug; 112():61-67. PubMed ID: 34971615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in Rates of Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the USA, 2012-2016.
    Sheyn D; Arora KS
    Matern Child Health J; 2021 Oct; 25(10):1562-1573. PubMed ID: 33970416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate Postpartum Long-Acting Reversible Contraception Programs in Texas Hospitals Following Changes to Medicaid Reimbursement Policy.
    Hill AV; Nehme E; Elerian N; Puga ED; Taylor BD; Lakey D; Patel DA
    Matern Child Health J; 2019 Dec; 23(12):1595-1603. PubMed ID: 31363887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents.
    Kortsmit K; Williams L; Pazol K; Smith RA; Whiteman M; Barfield W; Koumans E; Kourtis A; Harrison L; Bauman B; Warner L
    JAMA Pediatr; 2019 Jul; 173(7):663-670. PubMed ID: 31107513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counseling increases immediate postpartum Long-Acting Reversible Contraception (LARC) acceptability in Hispanic women.
    Cavanagh M; Dixon M; Bracamontes C; Reddy S
    J Gynecol Obstet Hum Reprod; 2022 Nov; 51(9):102457. PubMed ID: 35952927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of an educational video on long-acting reversible contraception (LARC) utilization at 6-8 weeks postpartum period: a randomized controlled trial.
    Burapasikarin C; Manonai J; Wattanayingcharoenchai R
    Arch Gynecol Obstet; 2020 Dec; 302(6):1503-1509. PubMed ID: 32734413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.